Profil
Benjamin Perry is the founder of MPC Therapeutics SA, holding the title of Director since 2018.
Dr. Perry is a Venture Partner at Medicxi Ventures (Jersey) Ltd. since 2022.
Education includes a doctorate from Imperial College London, conferred in 2002, and a graduate degree from Swansea University, conferred in 1999.
Aktive Positionen von Benjamin Perry
| Unternehmen | Position | Beginn |
|---|---|---|
Medicxi Ventures (Jersey) Ltd.
Medicxi Ventures (Jersey) Ltd. Investment ManagersFinance Medicxi invests in biopharma companies located in Europe. The firm provides financing for early and late stage capital requirements. | Private Equity Investor | 01.11.2022 |
MPC Therapeutics SA
MPC Therapeutics SA BiotechnologyHealth Technology Develops small molecules which modulate mitochondrial functions | Gründer | 01.01.2018 |
Ausbildung von Benjamin Perry
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Imperial College London
Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Swansea University
Swansea University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medicxi Ventures (Jersey) Ltd.
Medicxi Ventures (Jersey) Ltd. Investment ManagersFinance Medicxi invests in biopharma companies located in Europe. The firm provides financing for early and late stage capital requirements. | Finance |
MPC Therapeutics SA
MPC Therapeutics SA BiotechnologyHealth Technology Develops small molecules which modulate mitochondrial functions | Health Technology |
















